We are live on ! Find out more
TCOV

Trust Company of Vermont Portfolio holdings

AUM $2.68B
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.2B
AUM Growth
+$42.5M
Cap. Flow
+$2.61M
Cap. Flow %
0.22%
Top 10 Hldgs %
19.99%
Holding
1,087
New
93
Increased
215
Reduced
205
Closed
49

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$1.6M
2
BND icon
Vanguard Total Bond Market
BND
+$1.2M
3
MSM icon
MSC Industrial Direct
MSM
+$832K
4
AMAT icon
Applied Materials
AMAT
+$793K
5
JPM icon
JPMorgan Chase
JPM
+$775K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$1.18M
2
DD icon
DuPont de Nemours
DD
+$810K
3
FDX icon
FedEx
FDX
+$681K
4
XOM icon
ExxonMobil
XOM
+$545K
5
WFC icon
Wells Fargo
WFC
+$517K

Sector Composition

Rank Sector Weight
1 Technology 13.39%
2 Financials 13.27%
3 Healthcare 13.2%
4 Industrials 11.18%
5 Consumer Staples 9.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TT icon
501
Trane Technologies
TT
$106B
$37K ﹤0.01%
293
-11
-4% -$1.32K
BMI icon
502
Badger Meter
BMI
$3.8B
$36K ﹤0.01%
600
– –
EQR icon
503
Equity Residential
EQR
$24.8B
$36K ﹤0.01%
470
– –
PII icon
504
Polaris
PII
$3.92B
$36K ﹤0.01%
400
-40
-9% -$3.64K
EIX icon
505
Edison International
EIX
$27.4B
$34K ﹤0.01%
497
+250
+101% +$15.5K
GRC icon
506
Gorman-Rupp
GRC
$2.14B
$34K ﹤0.01%
1,025
– –
LNC icon
507
Lincoln National
LNC
$8.51B
$34K ﹤0.01%
520
– –
IBB icon
508
iShares Biotechnology ETF
IBB
$9.83B
$33K ﹤0.01%
300
– –
MU icon
509
Micron Technology
MU
$1.09T
$33K ﹤0.01%
843
-77
-8% -$2.93K
NYT icon
510
New York Times
NYT
$10.3B
$33K ﹤0.01%
1,000
– –
SKX
511
DELISTED
Skechers
SKX
$33K ﹤0.01%
1,050
– –
SNA icon
512
Snap-on
SNA
$20.9B
$33K ﹤0.01%
200
– –
FBGX
513
DELISTED
UBS AG FI Enhanced Large Cap Growth ETN
FBGX
$33K ﹤0.01%
121
-238
-66% -$62.2K
AVY icon
514
Avery Dennison
AVY
$13.5B
$32K ﹤0.01%
276
– –
BLUE
515
DELISTED
bluebird bio
BLUE
$32K ﹤0.01%
20
+6
+43% +$10.4K
ITA icon
516
iShares US Aerospace & Defense ETF
ITA
$14.8B
$32K ﹤0.01%
300
– –
IVE icon
517
iShares S&P 500 Value ETF
IVE
$50.1B
$32K ﹤0.01%
274
-135
-33% -$15.5K
RHP icon
518
Ryman Hospitality Properties
RHP
$7.87B
$32K ﹤0.01%
+400
New +$32.7K
FLG
519
Flagstar Bank National Association
FLG
$5.93B
$32K ﹤0.01%
1,068
– –
AZTA icon
520
Azenta
AZTA
$1.48B
$31K ﹤0.01%
800
– –
COO icon
521
Cooper Companies
COO
$15B
$31K ﹤0.01%
372
– –
NTRS icon
522
Northern Trust
NTRS
$34.7B
$31K ﹤0.01%
340
+300
+750% +$27.6K
VTV icon
523
Vanguard Morningstar Value ETF
VTV
$194B
$31K ﹤0.01%
278
– –
TWTR
524
DELISTED
Twitter, Inc.
TWTR
$31K ﹤0.01%
900
– –
GRUB
525
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$31K ﹤0.01%
200
– –
19 20
21
22 23

Similar funds

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
TCAM
Turtle Creek Asset Management Toronto, Ontario, Canada $2.67B AUM 0.64% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return

Trust Company of Vermont's Q2 2019 Portfolio in Review

As of Q2 2019, Trust Company of Vermont held 1,087 positions worth $1.2B, up 3.7% from $1.16B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trust Company of Vermont's Q2 2019 filing shows 93 new, 215 increased, 205 reduced and 49 closed positions. Its largest new stake was Dow Inc: 12,586 shares worth $620K. The largest sale was Novartis, an estimated $1.18M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • Trust Company of Vermont's largest Q2 2019 buy was Dow Inc: 12,586 shares worth $620K.
  • Trust Company of Vermont added most to CVS Health in Q2 2019, an estimated $1.6M increase.
  • Trust Company of Vermont's biggest Q2 2019 reduction was Novartis, cutting an estimated $1.18M.
  • Trust Company of Vermont fully exited Bemis in Q2 2019, selling an estimated $353K.
  • Trust Company of Vermont's ten largest holdings make up 20% of its $1.2B portfolio in Q2 2019.
  • Trust Company of Vermont opened 93 new positions and closed 49 in Q2 2019.
  • Trust Company of Vermont's portfolio value rose 3.7% quarter-over-quarter to $1.2B.

Based on Trust Company of Vermont's 13F filing for Q2 2019, filed 26 Jul 2019.